<DOC>
	<DOC>NCT00246584</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of long term treatment of SPP100 in patients with essential hypertension. (Trial is not recruiting in the US)</brief_summary>
	<brief_title>A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Diagnosed as essential hypertension Patients with secondary hypertension or suspected of having secondary hypertension. Patients suspected of having malignant hypertension Patients with any serious diseases or symptoms</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>angiotensin</keyword>
	<keyword>renin</keyword>
	<keyword>aliskiren</keyword>
</DOC>